- Report
- January 2022
- 293 Pages
Global
From €9184EUR$9,500USD£7,894GBP
Hysingla ER is a type of analgesic, or pain reliever, that is used to treat moderate to severe pain. It is an extended-release opioid medication, meaning it is designed to be taken once a day and to provide relief for up to 24 hours. Hysingla ER is a Schedule II controlled substance, meaning it has a high potential for abuse and addiction. It is typically prescribed for patients who require around-the-clock pain relief for an extended period of time.
Hysingla ER is available in both brand-name and generic forms. Some of the companies that produce Hysingla ER include Purdue Pharma, Endo Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more